Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.530
+0.035 (0.78%)
At close: Jun 8, 2026, 4:00 PM EDT
4.810
+0.280 (6.18%)
Pre-market: Jun 9, 2026, 7:34 AM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $60.14 million as of June 9, 2026. Its market cap has increased by 301.27% in one year.
Market Cap
60.14M
Enterprise Value
41.68M
1-Year Change
301.27%
Ranking
Category
Stock Price
$4.53
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $60.14M, a decrease of -6.45%. That is a compound annual growth rate of -1.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 60.14M | 105.08% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TScan Therapeutics | 64.95M |
| MediciNova | 63.99M |
| ImageneBio | 63.50M |
| iBio, Inc. | 62.53M |
| Seres Therapeutics | 60.82M |
| Acrivon Therapeutics | 60.35M |
| Impact BioMedical | 60.35M |
| Entera Bio | 59.07M |